The rapid emergence since the mid-2000s of a large and diverse range of substances
originally designed as legal alternatives to more established illicit drugs (pragmatically …

Psychoactive substances with chemical structures or pharmacological profiles that are
similar to traditional drugs of abuse continue to emerge on the recreational drug market …

Background New psychoactive substances constitute a growing and dynamic class of
abused drugs in the United States. On July 12, 2016, a synthetic cannabinoid caused mass …

Synthetic cannabinoid receptor agonists (SCRAs) are an evolving class of new psychoactive
substances (NPS) with structurally diverse compounds emerging each year. Due to the rapid …

Novel psychoactive substances (NPS) represent significant analytical and interpretive
challenges to forensic and clinical toxicologists. Timely access to case reports and reports of …

Synthetic cannabinoids (SCs) are a chemically diverse group of new psychoactive
substances (NPSs) that target the endocannabinoid system, triggering a plethora of actions …

Beginning in June of 2019, there was a marked increase in reported cases of serious
pulmonary injury associated with vaping. The condition, referred to as e-cigarette or vaping …

Abstract Introduction: Compounds present in Cannabis sativa such as phytocannabinoids
and terpenoids may act in concert to elicit therapeutic effects. Cannabinoids such as Δ9 …

In the last decades, more and more new psychoactive substances (NPS) were introduced on
the drug market which were sold as “legal” alternatives for classic drugs and misused …

Introduction: The emergence of novel psychoactive substances has changed the
epidemiology of drugs used recreationally throughout Europe and have posed significant …